• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The evolutional trajection and precision-medicine to gliomas

Research Project

Project/Area Number 20H03789
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 56010:Neurosurgery-related
Research InstitutionNagoya University

Principal Investigator

Natsume Atsushi  名古屋大学, 未来社会創造機構, 特任教授 (30362255)

Co-Investigator(Kenkyū-buntansha) 大岡 史治  名古屋大学, 医学系研究科, 講師 (10725724)
日野原 邦彦  名古屋大学, 医学系研究科, 特任准教授 (50549467)
青木 恒介  名古屋大学, 医学系研究科, 特任助教 (10759773)
Project Period (FY) 2020-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥17,680,000 (Direct Cost: ¥13,600,000、Indirect Cost: ¥4,080,000)
Fiscal Year 2022: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2021: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2020: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
Keywords脳腫瘍 / 数理モデル / 尿遺伝子解析 / ゲノム / シングルセル解析 / 遺伝子診断 / 進化トラジェクション / CRISPR/Cas9 / 神経膠腫 / DNAバーコードラベル / CRISPR/Cas9ノックアウト / シングルセル
Outline of Research at the Start

本課題では、これまでの組織レベルの研究ではわからなかった、腫瘍増殖を引き起こす進化遺伝子変異(evolutionary mutation)をシングルセルバーコード解析技術により探索し、腫瘍の寛解につながる治療法を見出すことを目的とする。IDH1変異やEZH2高発現に依存しなくなった進化的トラジェクションを引き起こす起因遺伝子を同定し、悪性転化により腫瘍増殖が制御不能になる前に介入できる新規薬剤を見出すことを最終的なゴールとする。本研究の科学的な裏付けをもって、悪性転化を阻止・遅延するというきめ細やかな治療戦略により、新規のプレシジョンメディシンの概念を確立する。

Outline of Final Research Achievements

In this study, we have established a novel mathematical model to predict the progression and malignant transformation of IDH-mutant glioma. This model would allow us to choose the best treatment option for the patients with those brain tumors, which is still under debates. Moreover, we have developed a urinary liquid genetic diagnosis system that is easy and less invasive. This technology can detect even an early brain tumors, regardless of tumor types, at over 90% of sensitivity and specificity. Our computed mathematical model and urinary-based next-gen diagnosis both have great potential to apply clinically and render patients to survive longer.

Academic Significance and Societal Importance of the Research Achievements

我々が作成したモデルは脳腫瘍の悪性度や大きさを問わず、正確に診断することができた。本研究から尿中のマイクロRNAは今後、脳腫瘍のバイオマーカーとして実用化される可能性が示された。本数理モデルによって、低悪性度IDH変異神経膠腫の各患者さんにとって、悪性化を防ぎ、結果として生存率を向上させる治療が提示できる。また、本解析アプローチは、新たな治療法や他の悪性腫瘍にも応用可能な汎用性の高いものである。

Report

(4 results)
  • 2023 Final Research Report ( PDF )
  • 2022 Annual Research Report
  • 2021 Annual Research Report
  • 2020 Annual Research Report
  • Research Products

    (14 results)

All 2023 2022 2021

All Journal Article (11 results) (of which Int'l Joint Research: 6 results,  Peer Reviewed: 11 results,  Open Access: 10 results) Presentation (3 results) (of which Int'l Joint Research: 1 results,  Invited: 2 results)

  • [Journal Article] Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors associated with glioblastoma stem-like properties.2023

    • Author(s)
      Das Nando D.、Chang Jen-Chien、Hon Chung-Chau、Kelly S. Thomas、Ito Shinsuke、Lizio Marina、Kaczkowski Bogumil、Watanabe Hisami、Katsushima Keisuke、Natsume Atsushi、Koseki Haruhiko、Kondo Yutaka、Minoda Aki、Umehara Takashi.
    • Journal Title

      BMC Genomics

      Volume: 24 Issue: 1 Pages: 574-574

    • DOI

      10.1186/s12864-023-09659-w

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas2023

    • Author(s)
      Kurimoto Michihiro、Rockenbach Yumi、Kato Akira、Natsume Atsushi
    • Journal Title

      Genes

      Volume: 14 Issue: 6 Pages: 1201-1201

    • DOI

      10.3390/genes14061201

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas2023

    • Author(s)
      Bredel Markus、Espinosa Llus、Kim Hyunsoo、Scholtens Denise M.、McElroy Joseph P.、Rajbhandari Rajani、Meng Wei、Kollmeyer Thomas M.、Malta Tathiane M.、Quezada Michael A.、Natsume Atsushi、Ogawa Seishi、Weber Ruthild G.、Pugh Stephanie L.、Chakravarti Arnab
    • Journal Title

      Cell Reports Medicine

      Volume: 4 Issue: 6 Pages: 101082-101082

    • DOI

      10.1016/j.xcrm.2023.101082

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsy2023

    • Author(s)
      Takahashi Hiromi、Yasui Takao、Hirano Masaki、Shinjo Keiko、Miyazaki Yusuke、Shinoda Wataru、Hasegawa Takeshi、Natsume Atsushi、Kitano Yotaro、Ida Mikiko、Zhang Min、Shimada Taisuke、Paisrisarn Piyawan、Zhu Zetao、Ohka Fumiharu、Aoki Kosuke、Rahong Sakon、Nagashima Kazuki、Yanagida Takeshi、Baba Yoshinobu
    • Journal Title

      Biosensors and Bioelectronics

      Volume: 234 Pages: 115318-115318

    • DOI

      10.1016/j.bios.2023.115318

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas2023

    • Author(s)
      Nishikawa Tomohide、Ohka Fumiharu、Aoki Kosuke、Suzuki Hiromichi、Motomura Kazuya、Yamaguchi Junya、Maeda Sachi、Kibe Yuji、Shimizu Hiroki、Natsume Atsushi、Innan Hideki、Saito Ryuta
    • Journal Title

      Brain Tumor Pathology

      Volume: 40 Issue: 2 Pages: 85-92

    • DOI

      10.1007/s10014-023-00459-4

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] All-in-One Nanowire Assay System for Capture and Analysis of Extracellular Vesicles from an <i>ex Vivo</i> Brain Tumor Model2023

    • Author(s)
      Chattrairat Kunanon、Yasui Takao、Suzuki Shunsuke、Natsume Atsushi、Nagashima Kazuki、Iida Mikiko、Zhang Min、Shimada Taisuke、Kato Akira、Aoki Kosuke、Ohka Fumiharu、Yamazaki Shintaro、Yanagida Takeshi、Baba Yoshinobu
    • Journal Title

      ACS Nano

      Volume: 17 Issue: 3 Pages: 2235-2244

    • DOI

      10.1021/acsnano.2c08526

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Electron-transfer kinetics through nucleic acids untangled by single-molecular fluorescence blinking2022

    • Author(s)
      Fan Shuya、Xu Jie、Osakada Yasuko、Hashimoto Katsunori、Takayama Kazuya、Natsume Atsushi、Hirano Masaki、Maruyama Atsushi、Fujitsuka Mamoru、Kawai Kumi、Kawai Kiyohiko
    • Journal Title

      Chem

      Volume: 8 Issue: 11 Pages: 3109-3119

    • DOI

      10.1016/j.chempr.2022.07.025

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas2022

    • Author(s)
      Natsume Atsushi、et al.
    • Journal Title

      Neuro-Oncology

      Volume: 25 Issue: 2 Pages: 326-336

    • DOI

      10.1093/neuonc/noac155

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma2022

    • Author(s)
      Chalise Lushun、Kato Akira、Ohno Masasuke、Maeda Sachi、Yamamichi Akane、Kuramitsu Shunichiro、Shiina Satoshi、Takahashi Hiromi、Ozone Sachiko、Yamaguchi Junya、Kato Yukinari、Rockenbach Yumi、Natsume Atsushi、Todo Tomoki
    • Journal Title

      Molecular Therapy - Oncolytics

      Volume: 26 Pages: 265-274

    • DOI

      10.1016/j.omto.2022.07.006

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas.2021

    • Author(s)
      Aoki K, Suzuki H, Yamamoto T, Yamamoto KN, Yamazaki S, Nakamura H, Takahashi M, Narita Y, Nakada M, Deguchi S, Mizoguchi M, Momii Y, Muragaki Y, Abe T, Akimoto J, Wakabayashi T, Saito R, Ogawa S, Haeno H, Natsume A.
    • Journal Title

      Cancer Res.

      Volume: 81 Pages: 4861-4873

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Newly established patient-derived organoid model of intracranial meningioma2021

    • Author(s)
      Yamazaki Shintaro、Ohka Fumiharu、Hirano Masaki、Shiraki Yukihiro、Motomura Kazuya et al
    • Journal Title

      Neuro-Oncology

      Volume: 23 Issue: 11 Pages: 1936-1948

    • DOI

      10.1093/neuonc/noab155

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Presentation] Urine-based genetic diagnosis of brain tumors.2023

    • Author(s)
      Atsushi NATSUME, Takao YASUI, Yoshinobu BABA
    • Organizer
      FIBER International Summit for Nucleic Acids 2023
    • Related Report
      2022 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] DNA/RNAを移動する電子速度の測定によるIDH1変異の検出2023

    • Author(s)
      夏目敦至、Fun Shuya, 平野雅規、高山和也、橋本克訓、丸山 厚、藤塚 守
    • Organizer
      第41回日本脳腫瘍病理学会
    • Related Report
      2022 Annual Research Report
  • [Presentation] Urine-based genetic diagnosis of brain tumors2023

    • Author(s)
      Atsushi NATSUME, Takao YASUI, Yoshinobu BABA
    • Organizer
      第61回日本癌治療学会
    • Related Report
      2022 Annual Research Report
    • Invited

URL: 

Published: 2020-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi